Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

about

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

Item

http://www.wikidata.org/entity/Q35959531

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@ast

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@en

type

Item

label

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@ast

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@en

prefLabel

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@ast

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@en

P1476

Visfatin expression and genetic polymorphism in patients with traumatic brain injury.

@en

P2093

Hong Xiao

http://www.w3.org/2001/XMLSchema#string

Ke Liu

http://www.w3.org/2001/XMLSchema#string

Li-Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Ming Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Inducing brain regeneration from within: in vivo reprogramming of endogenous somatic cells into neurons

Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities.

Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage.

Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.

Visfatin, glucose metabolism and vascular disease: a review of evidence.

Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.

Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.

P304

9799-9804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26309659

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

4538163

http://www.w3.org/2001/XMLSchema#string